Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
near normal blood sugars; feeling atrocious; low grade fever; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 15Oct2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 Diabetic" (ongoing). The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Oct2025, outcome "unknown", described as "feeling atrocious"; PYREXIA (non-serious) with onset Oct2025, outcome "unknown", described as "low grade fever"; THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset Oct2025, outcome "unknown", described as "near normal blood sugars". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Type 1 diabetic patient stated having consistent blood sugar levels after getting Covid 19 Vaccine since this morning (15Oct2025), despite feeling atrocious and having a low grade fever. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Type 1 diabetes mellitus
Test Date: 202510; Test Name: Blood sugar; Result Unstructured Data: Test Result:consistent blood sugar levels; Test Date: 202510; Test Name: body temperature; Result Unstructured Data: Test Result:low grade fever